CYNTHIA GUGGENMOS: Open Payments
NPI 1487207866 · BREWSTER, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 21 payments from 6 companies in 2025. Trend: 2023 $604 · 2024 $680 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $442 |
| ARGENX US, INC. | 3 | $89 |
| ACADIA Pharmaceuticals Inc | 3 | $50 |
| Lundbeck LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: QULIPTA, BOTOX, NUPLAZID, UBRELVY, VYVGART, VYEPTI, AJOVY, NURTEC ODT.
Industry payments across NE — which companies pay providers there.
